Bon Natural Life Limited(BON)Earnings, Financials & Key Ratios
BON•NASDAQ
$1.18
$7M mkt cap·Price updated May 6, 2026
AboutBon Natural Life Limited, together with its subsidiaries, engages in the research and development, manufacture, and sale of functional active ingredients extracted from natural herb plants in the People's Republic of China and internationally. The company provides personal care ingredients, such as plant extracted fragrance compounds to perfume and fragrance manufacturers; natural health supplements comprising powder drinks and bioactive food ingredient products primarily used as food additives; and nutritional supplements. Its products are principally used by manufacturer customers in the functional food, personal care, cosmetic, and pharmaceutical industries. The company was founded in 2006 and is headquartered in Grand Cayman, the Cayman Islands.Show more
- Revenue$19M-21.7%
- EBITDA-$337K-110.7%
- Net Income-$2M-601.0%
- EPS (Diluted)-0.72-523.5%
- Gross Margin20.77%-30.3%
- EBITDA Margin-1.81%-113.7%
- Operating Margin-8.69%-210.6%
- Net Margin-10.68%-739.8%
- ROE-3.9%-493.2%
- ROIC-2.11%-168.7%
- Debt/Equity0.21+29.1%
- Interest Coverage-3.67-209.2%
BON Key Insights
Bon Natural Life Limited (BON) fundamental analysis — strengths, weaknesses & financial health based on data analysis
✓Strengths
- ✓Trading at only 0.1x book value
✗Weaknesses
- ✗Weak 3Y average ROE of 3.7%
- ✗Weak Piotroski F-Score: 2/9
- ✗Negative free cash flow
- ✗Weak momentum: RS Rating 19 (bottom 19%)
- ✗Shares diluted 14.7% in last year
- ✗Trading more than 30% below 52-week high
* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.
BON Price & Volume
Bon Natural Life Limited (BON) stock price & volume — 10-year historical chart
Loading chart...
BON Growth Metrics
Bon Natural Life Limited (BON) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR
Revenue CAGR
10 Years-
5 Years0.49%
3 Years-14.54%
TTM-28.46%
Profit CAGR
10 Years-
5 Years-
3 Years-
TTM-114.74%
EPS CAGR
10 Years-
5 Years-
3 Years-
TTM-100.63%
Return on Capital
10 Years17.95%
5 Years13.29%
3 Years6.32%
Last Year-3.12%
BON Peer Comparison
Bon Natural Life Limited (BON) competitors in Food ingredients and pet food — business model, growth, and fundamentals comparison
| Company | Market Cap | Stock Price | P/E Ratio (TTM) | Revenue Growth 1Y | Net Margin | Return on Equity (ROE) | FCF Yield | Debt / Equity |
|---|---|---|---|---|---|---|---|---|
 SIEB | 70.34M | 1.74 | 5.27 | 16.09% | 7.95% | 0.08 | ||
 CHNR | 41.34M | 4.28 | -88.42 | -15.72% | ||||
 BYFC | 86.03M | 9.25 | -2.86 | -3.76% | -9.05% | 0.58 | ||
 NATR | 459.31M | 26.24 | 24.75 | 5.67% | 4.07% | 11.85% | 0.12 | |
 HAIN | 84.84M | 0.75 | -0.13 | -10.17% | -36.12% | -164.68% | 1.64 | |
 UNFI | 3.32B | 51.81 | -26.43 | 2.6% | -0.25% | -4.97% | 2.22 | |
 USFD | 23.6B | 92.05 | 31.31 | 4.08% | 1.43% | 12.48% | 1.21 | |
 SYY | 35.12B | 73.33 | 19.66 | 3.2% | 2.08% | 80.72% | 7.81 |
Compare BON vs Peers
Bon Natural Life Limited (BON) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.
BON Income Statement
Bon Natural Life Limited (BON) annual income statement — 10-year revenue, gross profit & net income history
10Y historyFree accessUpdated daily
| Line item | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 |
|---|---|---|---|---|---|---|---|---|
| Sales/Revenue | 10.78M | 16.4M | 18.22M | 25.49M | 29.91M | 29.52M | 23.84M | 18.67M |
| Revenue Growth % | - | 52.07% | 11.12% | 39.93% | 17.31% | -1.29% | -19.23% | -21.7% |
| Cost of Goods Sold | 8.41M | 11.11M | 13.02M | 18.38M | 20.48M | 20.68M | 16.73M | 14.79M |
| COGS % of Revenue | 77.99% | 67.78% | 71.45% | 72.1% | 68.49% | 70.06% | 70.18% | 79.23% |
| Gross Profit | 2.37M▲ 0% | 5.28M▲ 122.6% | 5.2M▼ 1.5% | 7.11M▲ 36.7% | 9.42M▲ 32.5% | 8.84M▼ 6.2% | 7.11M▼ 19.6% | 3.88M▼ 45.4% |
| Gross Margin % | 22.01% | 32.22% | 28.55% | 27.9% | 31.51% | 29.94% | 29.82% | 20.77% |
| Gross Profit Growth % | - | 122.62% | -1.51% | 36.71% | 32.5% | -6.19% | -19.57% | -45.45% |
| Operating Expenses | 1.77M | 2.11M | 1.73M | 1.71M | 2.88M | 2.9M | 5.24M | 5.5M |
| OpEx % of Revenue | 16.42% | 12.85% | 9.52% | 6.71% | 9.64% | 9.84% | 21.96% | 29.47% |
| Selling, General & Admin | 1.21M | 1.58M | 1.53M | 1.46M | 2.46M | 2.61M | 3.62M | 4.75M |
| SG&A % of Revenue | 11.26% | 9.66% | 8.39% | 5.74% | 8.22% | 8.82% | 15.16% | 25.43% |
| Research & Development | 556.09K | 522.87K | 205.36K | 249.05K | 424.56K | 298.47K | 1.62M | 754.19K |
| R&D % of Revenue | 5.16% | 3.19% | 1.13% | 0.98% | 1.42% | 1.01% | 6.8% | 4.04% |
| Other Operating Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Income | 602.14K▲ 0% | 3.18M▲ 427.3% | 3.47M▲ 9.2% | 5.4M▲ 55.7% | 6.54M▲ 21.1% | 5.92M▼ 9.5% | 1.87M▼ 68.3% | -1.62M▼ 186.6% |
| Operating Margin % | 5.58% | 19.37% | 19.04% | 21.18% | 21.87% | 20.05% | 7.86% | -8.69% |
| Operating Income Growth % | - | 427.31% | 9.23% | 55.72% | 21.1% | -9.5% | -68.35% | -186.64% |
| EBITDA | 826.23K | 3.4M | 3.7M | 5.69M | 6.91M | 7.1M | 3.15M | -337.2K |
| EBITDA Margin % | 7.66% | 20.75% | 20.3% | 22.31% | 23.1% | 24.06% | 13.21% | -1.81% |
| EBITDA Growth % | - | 311.73% | 8.73% | 53.76% | 21.49% | 2.78% | -55.63% | -110.7% |
| D&A (Non-Cash Add-back) | 224.08K | 226.63K | 230.6K | 286.69K | 369.5K | 1.18M | 1.28M | 1.29M |
| EBIT | 692.12K | 3.32M | 3.47M | 5.85M | 7.96M | 5.79M | 1.02M | -1.34M |
| Net Interest Income | -285.22K | -330.92K | -328.39K | -414.06K | -445.49K | -228.81K | -302.86K | -365.31K |
| Interest Income | 1.24K | 2.27K | 714 | 3.21K | 1.39K | 9.42K | 393 | 867 |
| Interest Expense | 286.46K | 333.19K | 329.1K | 417.27K | 446.88K | 238.22K | 303.25K | 366.18K |
| Other Income/Expense | -196.49K | -185.34K | 186.41K | 29.76K | 969.23K | -363.66K | -1.16M | -86.8K |
| Pretax Income | 405.65K▲ 0% | 2.99M▲ 637.0% | 3.65M▲ 22.2% | 5.43M▲ 48.6% | 7.51M▲ 38.3% | 5.55M▼ 26.0% | 715.94K▼ 87.1% | -1.71M▼ 338.8% |
| Pretax Margin % | 3.76% | 18.24% | 20.06% | 21.3% | 25.11% | 18.82% | 3% | -9.16% |
| Income Tax | 182.28K | 427.19K | 556.26K | 820.93K | 1.27M | 1M | 351.18K | 339.41K |
| Effective Tax Rate % | 44.93% | 14.29% | 15.22% | 15.12% | 16.87% | 18.04% | 49.05% | -19.85% |
| Net Income | 223.38K▲ 0% | 2.57M▲ 1052.2% | 3.03M▲ 17.6% | 4.59M▲ 51.7% | 6.24M▲ 35.9% | 4.6M▼ 26.3% | 398.17K▼ 91.3% | -1.99M▼ 601.0% |
| Net Margin % | 2.07% | 15.7% | 16.61% | 18.01% | 20.86% | 15.57% | 1.67% | -10.68% |
| Net Income Growth % | - | 1052.23% | 17.6% | 51.68% | 35.87% | -26.32% | -91.34% | -600.98% |
| Net Income (Continuing) | 223.38K | 2.56M | 3.1M | 4.61M | 6.24M | 4.55M | 364.76K | -2.05M |
| Discontinued Operations | 0 | 0 | 0 | 0 | 0 | 0 | -19.51K | 0 |
| Minority Interest | 0 | 425K | 506.73K | 527.87K | 530.49K | 497.18K | 442.85K | 447.06K |
| EPS (Diluted) | 0.43▲ 0% | 4.98▲ 1058.1% | 5.80▲ 16.5% | 170.00▲ 2831.0% | 185.75▲ 9.3% | 125.00▼ 32.7% | 0.17▼ 99.9% | -0.72▼ 523.5% |
| EPS Growth % | - | 1058.14% | 16.47% | 2831.03% | 9.26% | -32.71% | -99.86% | -523.53% |
| EPS (Basic) | 0.43 | 4.98 | 5.81 | 6.94 | 186.75 | 125.75 | 0.17 | -0.72 |
| Diluted Shares Outstanding | 516.67K | 516.67K | 521.07K | 670.62K | 839.61K | 919.81K | 2.4M | 2.76M |
| Basic Shares Outstanding | 516.67K | 516.67K | 521.84K | 675.12K | 842.9K | 919.2K | 2.28M | 2.76M |
| Dividend Payout Ratio | - | - | - | - | - | - | - | - |
BON Balance Sheet
Bon Natural Life Limited (BON) balance sheet — assets, liabilities & shareholders' equity
| Line item | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 |
|---|---|---|---|---|---|---|---|---|
| Total Current Assets | 13.45M | 8.58M | 10.84M | 16.55M | 14.72M | 24.18M | 39.79M | 45.76M |
| Cash & Short-Term Investments | 820.86K | 293.77K | 53.11K | 3.61M | 840.86K | 111.3K | 80.47K | 6.27M |
| Cash Only | 820.86K | 293.77K | 53.11K | 1.9M | 840.86K | 111.3K | 80.47K | 6.27M |
| Short-Term Investments | 0 | 0 | 0 | 1.7M | 0 | 0 | 0 | 0 |
| Accounts Receivable | 2.55M | 5.24M | 5.77M | 6.15M | 6.78M | 4.61M | 11.81M | 11.54M |
| Days Sales Outstanding | 86.47 | 116.57 | 115.61 | 88.09 | 82.79 | 57.01 | 180.85 | 225.6 |
| Inventory | 9.4M | 2.6M | 1.02M | 5.69M | 1.72M | 9.39M | 1.57M | 19.24M |
| Days Inventory Outstanding | 407.87 | 85.52 | 28.5 | 112.99 | 30.68 | 165.69 | 34.29 | 474.85 |
| Other Current Assets | 0 | 367.66K | 501.08K | 1M | 277.51K | 10.07M | 11.86M | 8.71M |
| Total Non-Current Assets | 3.19M | 10.98M | 14.36M | 19.86M | 22.54M | 22.37M | 21.97M | 39.43M |
| Property, Plant & Equipment | 3.01M | 9.5M | 14.17M | 19.43M | 22.17M | 21.38M | 15.15M | 18.27M |
| Fixed Asset Turnover | 3.58x | 1.73x | 1.29x | 1.31x | 1.35x | 1.38x | 1.57x | 1.02x |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 147.97K | 138.37K | 140.99K | 411.06K | 366.17K | 995.23K | 777K | 6.42M |
| Long-Term Investments | -35.53K | 0 | -510.08K | 0 | 22.54M | 22.37M | 0 | 14.73M |
| Other Non-Current Assets | 35.53K | 1.31M | 510.08K | 0 | -22.54M | -22.37M | 6.05M | 0 |
| Total Assets | 16.64M▲ 0% | 19.56M▲ 17.5% | 25.2M▲ 28.8% | 36.41M▲ 44.5% | 37.26M▲ 2.3% | 46.56M▲ 25.0% | 61.77M▲ 32.7% | 85.19M▲ 37.9% |
| Asset Turnover | 0.65x | 0.84x | 0.72x | 0.70x | 0.80x | 0.63x | 0.39x | 0.22x |
| Asset Growth % | - | 17.52% | 28.84% | 44.48% | 2.32% | 24.96% | 32.67% | 37.92% |
| Total Current Liabilities | 8.75M | 10.86M | 11.7M | 7.53M | 6.65M | 9.61M | 16.45M | 26.31M |
| Accounts Payable | 2.72M | 3.22M | 1.29M | 380.38K | 214.59K | 1.4M | 3.43M | 7.64M |
| Days Payables Outstanding | 118.21 | 105.78 | 36.13 | 7.55 | 3.82 | 24.79 | 74.77 | 188.55 |
| Short-Term Debt | 3.18M | 4.3M | 3.21M | 713.54K | 4.63M | 3.16M | 6.18M | 11.41M |
| Deferred Revenue (Current) | 0 | 0 | 385.98K | 1.1M | 188.75K | 106.51K | 506.77K | 219.68K |
| Other Current Liabilities | 702.62K | 2.74M | 6.73M | 3.65M | 576.1K | 2.8M | 11.54K | 2.16M |
| Current Ratio | 1.54x | 0.79x | 0.93x | 2.20x | 2.21x | 2.52x | 2.42x | 1.74x |
| Quick Ratio | 0.46x | 0.55x | 0.84x | 1.44x | 1.95x | 1.54x | 2.32x | 1.01x |
| Cash Conversion Cycle | 376.13 | 96.3 | 107.98 | 193.53 | 109.66 | 197.9 | 140.37 | 511.9 |
| Total Non-Current Liabilities | 3.35M | 1.43M | 2.48M | 2.35M | 517.01K | 963.09K | 970.06K | 879.41K |
| Long-Term Debt | 3.35M | 1.4M | 2.48M | 2.32M | 189.81K | 963.09K | 970.06K | 879.42K |
| Capital Lease Obligations | 0 | 31.82K | 0 | 175.66K | 327.2K | 91.72K | 0 | 36.6K |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | -146.7K | 0 | -91.72K | 0 | -36.6K |
| Total Liabilities | 12.1M | 12.3M | 14.18M | 9.88M | 7.16M | 10.57M | 17.42M | 27.19M |
| Total Debt | 6.53M | 6.09M | 5.72M | 3.21M | 5.41M | 4.21M | 7.3M | 12.32M |
| Net Debt | 5.71M | 5.8M | 5.67M | 1.31M | 4.57M | 4.09M | 7.22M | 6.06M |
| Debt / Equity | 1.44x | 0.84x | 0.52x | 0.12x | 0.18x | 0.12x | 0.16x | 0.21x |
| Debt / EBITDA | 7.91x | 1.79x | 1.55x | 0.56x | 0.78x | 0.59x | 2.32x | - |
| Net Debt / EBITDA | 6.91x | 1.71x | 1.53x | 0.23x | 0.66x | 0.58x | 2.29x | - |
| Interest Coverage | 2.42x | 9.97x | 10.54x | 14.01x | 17.80x | 24.32x | 3.36x | -3.67x |
| Total Equity | 4.55M▲ 0% | 7.26M▲ 59.8% | 11.02M▲ 51.8% | 26.53M▲ 140.7% | 30.09M▲ 13.4% | 35.98M▲ 19.6% | 44.35M▲ 23.3% | 58M▲ 30.8% |
| Equity Growth % | - | 59.76% | 51.76% | 140.72% | 13.41% | 19.57% | 23.26% | 30.77% |
| Book Value per Share | 8.80 | 14.06 | 21.15 | 39.57 | 35.84 | 39.12 | 18.46 | 21.05 |
| Total Shareholders' Equity | 4.55M | 6.84M | 10.52M | 26.01M | 29.56M | 35.48M | 43.91M | 57.55M |
| Common Stock | 517 | 517 | 580 | 833 | 840 | 1.17K | 3.97K | 154.22K |
| Retained Earnings | 52.12K | 2.37M | 5.07M | 9.19M | 14.68M | 18.7M | 18.74M | 16.63M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -546.35K | -570.83K | 191.82K | 1.27M | -827.05K | -1.31M | 155.94K | -26.13K |
| Minority Interest | 0 | 425K | 506.73K | 527.87K | 530.49K | 497.18K | 442.85K | 447.06K |
BON Cash Flow Statement
Bon Natural Life Limited (BON) cash flow — operating, investing & free cash flow history
| Line item | Sep'18 | Sep'19 | Sep'20 | Sep'21 | Sep'22 | Sep'23 | Sep'24 | Sep'25 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 273.9K | 7.1M | 2.64M | 4.05M | -187.12K | -651.91K | -7.72M | 141.12K |
| Operating CF Margin % | 2.54% | 43.33% | 14.51% | 15.9% | -0.63% | -2.21% | -32.39% | 0.76% |
| Operating CF Growth % | - | 2493.98% | -62.8% | 53.35% | -104.62% | -248.39% | -1084.78% | 101.83% |
| Net Income | 223.38K | 2.57M | 3.03M | 4.59M | 6.24M | 4.61M | 417.68K | -1.99M |
| Depreciation & Amortization | 224.08K | 226.63K | 230.6K | 286.69K | 369.5K | 1.18M | 1.28M | 1.29M |
| Stock-Based Compensation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Taxes | 61.48K | -5.15K | -7.75K | 29.11K | 19.01K | 1.41K | 0 | 0 |
| Other Non-Cash Items | 275.67K | 17.88K | 103.42K | -200.9K | 18.02K | -6.7M | 2.25M | 2.3M |
| Working Capital Changes | -510.72K | 4.29M | -709.86K | -652.58K | -6.83M | 249.45K | -11.67M | -1.45M |
| Change in Receivables | -145.38K | -2.91M | -284.55K | -89.54K | -1.3M | 2.08M | -6.81M | -108.81K |
| Change in Inventory | 452.85K | 6.68M | -1.39M | -608.27K | -564.73K | -3.84M | -6.12M | -3.83M |
| Change in Payables | -1.12M | -78.36K | -1.98M | -969.41K | -141.93K | 833.55K | 1.92M | 6.11M |
| Cash from Investing | -1.68M | -7.99M | -3M | -7.44M | -3.06M | -1.19M | -15.73K | -10M |
| Capital Expenditures | -1.68M | -8.43M | -4.33M | -4.75M | -4.74M | -731.1K | -7.05K | -10M |
| CapEx % of Revenue | 15.62% | 51.41% | 23.78% | 18.65% | 15.83% | 2.48% | 0.03% | 53.54% |
| Acquisitions | 0 | 435.96K | 1.33M | -1M | 1.61K | 0 | 0 | 0 |
| Investments | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | 0 | 0 | -454.5K | -8.74K | 0 |
| Cash from Financing | 2.02M | 368.72K | 112.49K | 5.35M | 2.26M | 1.16M | 8.76M | 15.45M |
| Debt Issued (Net) | 2.02M | 368.72K | 394.05K | -5.4M | 2.26M | -875.36K | 3.15M | 4.78M |
| Equity Issued (Net) | 0 | 0 | 0 | 11.27M | 140 | 2.03M | 5.6M | 10.67M |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Financing | 0 | 0 | -281.55K | -521.65K | 0 | 3.06K | 5K | 0 |
| Net Change in Cash | 820.86K▲ 0% | -527.09K▼ 164.2% | -240.66K▲ 54.3% | 1.85M▲ 869.0% | -1.06M▼ 157.4% | -729.56K▲ 31.4% | 545.91K▲ 174.8% | 5.61M▲ 927.4% |
| Free Cash Flow | -1.41M▲ 0% | 29.93K▲ 102.1% | -1.69M▼ 5746.0% | -700.78K▲ 58.5% | -4.92M▼ 602.5% | -713.82K▲ 85.5% | -7.73M▼ 982.9% | -4.23M▲ 45.3% |
| FCF Margin % | -13.08% | 0.18% | -9.28% | -2.75% | -16.46% | -2.42% | -32.42% | -22.66% |
| FCF Growth % | - | 102.12% | -5746.03% | 58.53% | -602.49% | 85.5% | -982.89% | 45.27% |
| FCF per Share | -2.73 | 0.06 | -3.24 | -1.04 | -5.86 | -0.78 | -3.22 | -1.54 |
| FCF Conversion (FCF/Net Income) | 1.23x | 2.76x | 0.87x | 0.88x | -0.03x | -0.14x | -19.40x | -0.07x |
| Interest Paid | 286.46K | 333.19K | 0 | 417.27K | 446.88K | 238.22K | 303.32K | 0 |
| Taxes Paid | 336.39K | 115.18K | 0 | 2.41K | 2.29M | 478.68K | 0 | 0 |
BON Key Ratios
Bon Natural Life Limited (BON) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios
| Metric | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Return on Equity (ROE) | 4.91% | 43.59% | 33.1% | 24.45% | 22.03% | 13.91% | 0.99% | -3.9% |
| Return on Invested Capital (ROIC) | 4.4% | 20.42% | 17.48% | 18.19% | 15.7% | 11.88% | 3.07% | -2.11% |
| Gross Margin | 22.01% | 32.22% | 28.55% | 27.9% | 31.51% | 29.94% | 29.82% | 20.77% |
| Net Margin | 2.07% | 15.7% | 16.61% | 18.01% | 20.86% | 15.57% | 1.67% | -10.68% |
| Debt / Equity | 1.44x | 0.84x | 0.52x | 0.12x | 0.18x | 0.12x | 0.16x | 0.21x |
| Interest Coverage | 2.42x | 9.97x | 10.54x | 14.01x | 17.80x | 24.32x | 3.36x | -3.67x |
| FCF Conversion | 1.23x | 2.76x | 0.87x | 0.88x | -0.03x | -0.14x | -19.40x | -0.07x |
| Revenue Growth | - | 52.07% | 11.12% | 39.93% | 17.31% | -1.29% | -19.23% | -21.7% |
BON Frequently Asked Questions
Bon Natural Life Limited (BON) stock FAQ — growth, dividends, profitability & financials explained
Growth & Financials
Bon Natural Life Limited (BON) reported $42.5M in revenue for fiscal year 2025. This represents a 294% increase from $10.8M in 2018.
Bon Natural Life Limited (BON) saw revenue decline by 21.7% over the past year.
Bon Natural Life Limited (BON) reported a net loss of $1.6M for fiscal year 2025.
Dividend & Returns
Bon Natural Life Limited (BON) has a return on equity (ROE) of -3.9%. Negative ROE indicates the company is unprofitable.
Bon Natural Life Limited (BON) had negative free cash flow of $12.0M in fiscal year 2025, likely due to heavy capital investments.
Explore More BON
Bon Natural Life Limited (BON) financial analysis — history, returns, DCA and operating performance tools
Total Return Calculator
Historical returns with dividends reinvested
DCA Calculator
Dollar cost averaging vs lump sum
Dividend History
Yield, growth, payout safety & DRIP
Earnings History
EPS trends, net income & profitability
Price History
Long-term charts & historical price data
Revenue History
Sales growth patterns & revenue breakdown
Financial Ratios
30 years of market, efficiency and balance-sheet ratios
Valuation
DCF intrinsic value, peer multiples & estimates